Koninklijke DSM NV
AEX:DSM
Koninklijke DSM NV
Revenue
Koninklijke DSM NV
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Koninklijke DSM NV
AEX:DSM
|
Revenue
€8.4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Corbion NV
AEX:CRBN
|
Revenue
€1.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
Akzo Nobel NV
AEX:AKZA
|
Revenue
€10.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-3%
|
See Also
What is Koninklijke DSM NV's Revenue?
Revenue
8.4B
EUR
Based on the financial report for Dec 31, 2022, Koninklijke DSM NV's Revenue amounts to 8.4B EUR.
What is Koninklijke DSM NV's Revenue growth rate?
Revenue CAGR 5Y
-1%
Over the last year, the Revenue growth was 15%. The average annual Revenue growth rates for Koninklijke DSM NV have been 2% over the past three years , -1% over the past five years .